Preferred Label : luprolide acetate gel depot;
MeSH note : Eligard is Atrix Laboratories, Inc. formulation composed of a biodegradable poly (DL-lactide-co-glycolide)
polymer dissolved in a biocompatible solvent, N-methyl-2-pyrrolidone;;
Is substance : O;
Origin ID : C493311;
UMLS CUI : C1529122;
MeSH indexing information
- MeSH term(s) associated for indexing
- Record concept(s)
- Semantic type(s)
https://www.ansm.sante.fr/actualites/leuproreline-injectable-eligard-enantone-lp-leptoprol-injections-a-realiser-exclusivement-par-des-professionnels-de-sante-ayant-une-bonne-connaissance-des-etapes-de-reconstitution-administration
2020
false
false
false
France
French
guidelines for drug use
eligard
health personnel
knowledge
enantone
injections
injection, nos
insight, nos
wellness state
acquaintance
Injection moulding
health
leuprolide
luprolide acetate gel depot
health
---
https://ansm.sante.fr/informations-de-securite/eligard-poudre-et-solvant-pour-solution-injectable-acetate-de-leuproreline-reevaluation-des-conditions-de-prescription-et-de-delivrance-realisation-dun-dosage-de-la-testosteronemie
2016
false
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
medication errors
Inappropriate reconstitution technique
injections, subcutaneous
luprolide acetate gel depot
leuprorelin
antineoplastic agents, hormonal
Drug maladministration
drug prescriptions
continuity of patient care
Blood testosterone
testosterone
advanced hormone-dependent prostate cancer
prostatic neoplasms
neoplasms, hormone-dependent
leuprolide
---
http://www.has-sante.fr/portail/jcms/c_2044634/fr/eligard
2015
false
France
French
advanced hormone-dependent prostate cancer
Locally Advanced Malignant Neoplasm
chemoradiotherapy
evaluation of the transparency committee
injections, subcutaneous
luprolide acetate gel depot
insurance, health, reimbursement
antineoplastic agents, hormonal
prostatic neoplasms
neoplasms, hormone-dependent
leuprorelin
treatment outcome
luprolide acetate gel depot
antineoplastic agents, hormonal
Delayed-Action preparations
leuprolide
leuprolide
---
http://www.has-sante.fr/portail/jcms/c_1627494/fr/eligard
http://www.has-sante.fr/portail/jcms/c_1627493/fr/eligard-24072013-avis-ct8849
http://www.has-sante.fr/portail/display.jsp?id=c_619565
http://www.has-sante.fr/portail/display.jsp?id=c_400706
2013
France
French
evaluation of the transparency committee
injections, subcutaneous
luprolide acetate gel depot
insurance, health, reimbursement
antineoplastic agents, hormonal
prostatic neoplasms
neoplasms, hormone-dependent
leuprorelin
treatment outcome
luprolide acetate gel depot
antineoplastic agents, hormonal
Delayed-Action preparations
leuprolide
leuprolide
---
